|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-9-3
|
|
pubmed:abstractText |
Given the high incidence (1.5%-10%) of invasive aspergillosis (IA) after liver transplantation and the associated mortality, prophylaxis according to the patients' circumstances is a reasonable approach. The purpose of this investigation was to determine the effect and significance of risk factors for IA in a specialized transplantation center.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1439-0973
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
313-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19629387-Adult,
pubmed-meshheading:19629387-Antifungal Agents,
pubmed-meshheading:19629387-Aspergillosis,
pubmed-meshheading:19629387-Chemoprevention,
pubmed-meshheading:19629387-Female,
pubmed-meshheading:19629387-Germany,
pubmed-meshheading:19629387-Hospitals, University,
pubmed-meshheading:19629387-Humans,
pubmed-meshheading:19629387-Immunosuppressive Agents,
pubmed-meshheading:19629387-Itraconazole,
pubmed-meshheading:19629387-Liver Transplantation,
pubmed-meshheading:19629387-Male,
pubmed-meshheading:19629387-Middle Aged,
pubmed-meshheading:19629387-Risk Factors,
pubmed-meshheading:19629387-Transplantation
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A risk profile for invasive aspergillosis in liver transplant recipients.
|
|
pubmed:affiliation |
Pharmacy Dept., University Hospital of Heidelberg, Heidelberg, Germany. maike.rosenhagen@med.uni-heidelberg.de
|
|
pubmed:publicationType |
Journal Article
|
